Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to -$1.7 billion.

  • Ironwood Pharmaceuticals' Retained Earnings rose 167.94% to -$1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 billion, marking a year-over-year increase of 167.94%. This contributed to the annual value of -$1.7 billion for FY2024, which is 5.18% up from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Retained Earnings stood at -$1.7 billion for Q3 2025, which was up 167.94% from -$1.7 billion recorded in Q2 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' Retained Earnings peaked at -$650.7 million during Q1 2023, and registered a low of -$1.7 billion during Q1 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' median Retained Earnings value was -$1.7 billion (recorded in 2025), while the average stood at -$1.3 billion.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Retained Earnings skyrocketed by 4161.54% in 2022 and then tumbled by 16169.92% in 2024.
  • Over the past 5 years, Ironwood Pharmaceuticals' Retained Earnings (Quarter) stood at -$937.6 million in 2021, then rose by 25.73% to -$696.4 million in 2022, then crashed by 143.92% to -$1.7 billion in 2023, then rose by 0.05% to -$1.7 billion in 2024, then grew by 1.55% to -$1.7 billion in 2025.
  • Its Retained Earnings stands at -$1.7 billion for Q3 2025, versus -$1.7 billion for Q2 2025 and -$1.7 billion for Q1 2025.